Feds Approve Amerisource Merger with Bergen

Biopure announces favorable result for Hemopure trial; Blockbuster shares sag as Hollywood catches video-on-demand fever; plus more of today's stocks in the news

Amerisource Health (AAS ) announced the FTC approval of a merger of Americsource and Bergen Brunswig. Salomon raised estimates. CS First Boston raises target and reiterates buy. Bear Stearns rates buy.

Biopure Corp. (BPUR ) announced that a clinical trial showed overall medical risk to patients receiving its Hemopure product are no greater than those receiving donated red blood cells.

Blockbuster (BBI ) slides after press reports say Hollywood studios are getting serious about video on demand.

Sulzer Medical (SM ) Reportedly says it may issue new ADRs if its proposal for a settlement of lawsuits resulting from faulty hip implants is accepted.

UBS Warburg raised estimates and maintains buy on Virata Corp. (VRTA ). CS First Boston reiterates buy.

Robinson Humphrey downgraded Synovus Financial (SNV ) to outperform from buy on valuation.

Goldman sees a trading opportunity, and reiterates recommended list for International Game Technology (IGT ).

IBM Corp. (IBM ) says it has built and demonstrated the first logic-performing computer circuit within a single molecule, whcih could lead to a new class of smaller, faster computers that consume less power than today's machines.

Goldman cut Q3 EPS estimates on Charles Schwab (SCH ) Morgan Stanley Dean Witter (MWD ) and Lehman Brothers (LEH ).

RWE and a German utility group, are considering a $3.6B bid for American Water Works (AWK ), according to press reports.

Centillium Communications (CTLM ) reaffirmed guidance for $46M Q3 revenues and $0.08 EPS. The company announced the resignation of John Luhtala as CFO. UBS Warburg raised its estimates, and Frost Securities reiterates strong buy.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE